These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35101183)

  • 1. Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial.
    Turner S; Cotton S; Wood J; Bell V; Raja EA; Scott NW; Morgan H; Lawrie L; Emele D; Kennedy C; Scotland G; Fielding S; MacLennan G; Norrie J; Forrest M; Gaillard EA; de Jongste J; Pijnenburg M; Thomas M; Price D
    Lancet Respir Med; 2022 Jun; 10(6):584-592. PubMed ID: 35101183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO).
    Turner S; Cotton SC; Emele CD; Thomas R; Fielding S; Gaillard EA; de Jongste JC; Morgan H; Neilson AR; Norrie J; Pijnenburg M; Price D; Thomas M
    Trials; 2019 Oct; 20(1):573. PubMed ID: 31585544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial.
    Hale EM; Greene G; Mulvey C; Mokoka MC; van Boven JFM; Cushen B; Sulaiman I; Brennan V; Lombard L; Walsh J; Plunkett S; McCartan TA; Kerr PJ; Reilly RB; Hughes C; Kent BD; Jackson DJ; Butler M; Counihan I; Hayes J; Faul J; Kelly M; Convery R; Nanzer AM; Fitzgerald JM; Murphy DM; Heaney LG; Costello RW;
    Lancet Respir Med; 2023 Jul; 11(7):591-601. PubMed ID: 36963417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
    Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID;
    Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
    Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID
    Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled nitric oxide levels to guide treatment for children with asthma.
    Petsky HL; Kew KM; Chang AB
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011439. PubMed ID: 27825189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li A; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006340. PubMed ID: 19821360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health.
    Murphy VE; Jensen ME; Mattes J; Hensley MJ; Giles WB; Peek MJ; Bisits A; Callaway LK; McCaffery K; Barrett HL; Colditz PB; Seeho SK; Attia J; Searles A; Doran C; Powell H; Gibson PG
    BMC Pregnancy Childbirth; 2016 May; 16():111. PubMed ID: 27189595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
    McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
    Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
    Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
    Pavord ID; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Williams M; Weatherall M; Beasley R;
    Lancet Respir Med; 2020 Jul; 8(7):671-680. PubMed ID: 32171064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial.
    Price DB; Buhl R; Chan A; Freeman D; Gardener E; Godley C; Gruffydd-Jones K; McGarvey L; Ohta K; Ryan D; Syk J; Tan NC; Tan T; Thomas M; Yang S; Konduru PR; Ngantcha M; d'Alcontres MS; Lapperre TS
    Lancet Respir Med; 2018 Jan; 6(1):29-39. PubMed ID: 29108938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.
    Pike K; Selby A; Price S; Warner J; Connett G; Legg J; Lucas JS; Peters S; Buckley H; Magier K; Foote K; Drew K; Morris R; Lancaster N; Roberts G
    Clin Respir J; 2013 Apr; 7(2):204-13. PubMed ID: 22747899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li AM; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006340. PubMed ID: 18425949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
    Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
    Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial.
    Syk J; Malinovschi A; Johansson G; Undén AL; Andreasson A; Lekander M; Alving K
    J Allergy Clin Immunol Pract; 2013; 1(6):639-48.e1-8. PubMed ID: 24565712
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.